 VICTORIA, British Columbia--BUSINESS WIRE--- IPA POLYTOPE--IMMUNOPRECISE ANTIBODIES LTD. the Company or IPA NASDAQ:IPA TSX VENTURE:IPA a leader in full-service, therapeutic antibody discovery and development, today announced the Company will host a conference call to discuss its financial results and business highlights for the full fiscal year 2021, on Wednesday, July 28, 2021, after the close of market. The financial results will be issued in a press release prior to the call. ImmunoPrecise manag 